July 10, 2025

1 in 4 US Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

July 09, 2025

Recombinant Zoster Vaccine Linked to New-Onset Lupus

Researchers report the first documented case of systemic lupus erythematosus following Shingrix vaccination.

Conexiant

July 09, 2025

Upadacitinib Cuts Flares, Steroids in GCA Trial

A new phase 3 study found that daily oral upadacitinib 15 mg, combined with a shorter 26-week steroid taper, improved sustained remission rates and reduced steroid use in patients with giant-cell arteritis.

Conexiant

July 09, 2025

Oral Bacteria Linked to Brain, Gene Risk

A study of older adults found that specific oral bacteria were linked to cognitive performance and genetic risk for Alzheimer’s, while other microbes showed stronger associations in people with mild cognitive impairment.

Conexiant

July 08, 2025

Natural Cycle Beats HRT in FET Outcomes

A randomized trial found that using a natural cycle to prepare the endometrium for frozen embryo transfer in ovulatory women led to higher live birth rates and fewer complications compared to hormone replacement therapy.

Conexiant

July 07, 2025

FDA Approves First Oral Hereditary Angioedema Treatment

FDA approves Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema, shown in trials to provide faster symptom relief and eliminate the need for injection.

Conexiant

July 07, 2025

Can Gene Therapy Restore Hearing?

A new gene therapy trial shows rapid, significant hearing improvement in children and adults with inherited deafness caused by OTOF mutations.

Conexiant

July 07, 2025

Newborns Show Higher p-tau217 Than Alzheimer’s Patients

Newborns have higher levels of phosphorylated tau217 in their blood than even patients with Alzheimer’s disease, a new study finds, raising new questions about the dual role of tau in brain development and degeneration.

Conexiant

July 03, 2025

Sonelokimab, Biologics Show Benefit in Hidradenitis Suppurativa

A systematic review and network meta-analysis of clinical trials found that several biologic and small-molecule therapies provided short-term improvement in adults with moderate to severe hidradenitis suppurativa, a chronic inflammatory skin disease.

Conexiant